Cromos Pharma supporting Blood Cancer Awareness Month September is Blood Cancer Awareness Month. Approximately 1.24 million blood cancer cases occur annually worldwide, accounting for almost 6% of all cancer cases. In the US, blood cancers are the third leading cause of cancer deaths yet the impact of these cancers is under recognized. Despite recent progress in blood cancer research, more than 1/3 of blood
Cromos Pharma committed to supporting clinical research into Alzheimer’s disease This September Cromos Pharma is highlighting World Alzheimer’s Month. Alzheimer’s Disease (AD) is the most well-known form of dementia. Dementia is the collective name for progressive brain conditions affecting memory, thinking, behavior and emotions. Dementia affects almost 50 million people worldwide. While aging is a major risk factor for dementia, it also affects people under 65 years. There are over
5 key takeaways from World Orphan Drug Congress USA Cromos Pharma’s US BDD Nicole Brenna attended World Orphan Drug Congress USA (August 25-27, 2021) in Maryland. It was Cromos Pharma’s first in-person conference since the outbreak of the COVID-19 pandemic. Read Nicole’s 5 key takeaways from the event. The World Orphan Drug Congress USA (WODCUS) took place over two days in Maryland (August 25-27,
